CVS/Aetna To Merge In Defensive Play To Reshape Health-Care Delivery
Executive Summary
The pharmacy retail chain and drug distributor will buy the insurer for $69bn in a merger to build what the companies say will be a new, more affordable health-care concept.
You may also be interested in...
Biopharma Quarterly Deal-making Statistics, Q4 2017
Biopharma financing finished off 2017 strong with a total value of $14.5 billion in Q4, led again by FOPOs. CVS' massive $77 billion acquisition of Aetna resulted in an all-time quarterly high in the M&A category, and the largest alliances were dominated by the development of vaccines and antibodies.
New Mega Health-Care Trio Offers Opportunity For Digital Sector
A new independent health-care company created by Amazon, Berkshire Hathaway and JPMorgan will put an emphasis on using technology to "simplify" health care. That is music to the ears of digital-health firms.
Bumpy Ride Awaits Indian Firms In 2018 (And Then There’s Amazon)
2018 may not be smooth sailing for Indian firms, going by the predictions of top industry pundits. Possible upheavals on the domestic market, dynamics that demand a hawk eye on expenses and gains but also pressures as a result of FDA reforms suggest that a relatively tough year may be in store.